Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 5/2004

01-10-2004 | Original Paper

The impact of dietary oxalate on kidney stone formation

Authors: Ross P. Holmes, Dean G. Assimos

Published in: Urolithiasis | Issue 5/2004

Login to get access

Abstract

The role of dietary oxalate in calcium oxalate kidney stone formation remains unclear. However, due to the risk for stone disease that is associated with a low calcium intake, dietary oxalate is believed to be an important contributing factor. In this review, we have examined the available evidence related to the ingestion of dietary oxalate, its intestinal absorption, and its handling by the kidney. The only difference identified to date between normal individuals and those who form stones is in the intestinal absorption of oxalate. Differences in dietary oxalate intake and in renal oxalate excretion are two other parameters that are likely to receive close scrutiny in the near future, because the research tools required for these investigations are now available. Such research, together with more extensive examinations of intestinal oxalate absorption, should help clarify the role of dietary oxalate in stone formation.
Literature
1.
Zarembski PM, Hodgkinson A (1969) Some factors influencing the urinary excretion of oxalic acid in man. Clinica Chimica Acta 25: 1CrossRef
2.
Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59: 270CrossRefPubMed
3.
Holmes RP, Kennedy M (2000) Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 57: 1662CrossRefPubMed
4.
Siener R, Ebert D, Nicolav C, Hesse A (2003) Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 63: 1037CrossRefPubMed
5.
Honow R, Hesse A (2002) Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem 78: 511CrossRef
6.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833
7.
Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scanning Microsc 9: 1109PubMed
8.
Hesse A, Schneeberger W, Engfeld S, Unruh GEV, Sauerbruch T (1999) Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol 10 [Suppl 14]: S329
9.
Hatch M, Freel RW, Vaziri ND (1999) Regulatory aspects of oxalate secretion in enteric oxalate elimination. J Am Soc Nephrol 10 [Suppl 14]: S324
10.
Krishnamurthy M, Hruska KA, Chandhoke PS (2003) The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol 169: 2030PubMed
11.
Prenen JAC, Boer P, Mees EJD (1984) Absorption kinetics of oxalate from oxalate-rich food in man. Am J Clin Nutr 40: 1007PubMed
12.
Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13: 2241CrossRefPubMed
13.
Liebman M, Chai W (1997) Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr 65: 1453PubMed
14.
Sidhu H, Schmidt ME, CorneliusT JG, Thamiselvam S, Khan SR, Hesse A, Peck AB (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10: S334PubMed
15.
Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H (2003) Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10: 293CrossRefPubMed
16.
Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17: 173CrossRefPubMed
17.
Unruh GE von, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2] oxalate absorption test. J Urol 169: 687PubMed
18.
Holmes RP, Assimos DG, Goodman HO (1998) Genetic and dietary influences on urinary oxalate excretion. Urol Res 26: 195CrossRefPubMed
19.
Mount DB, Romero MF (2004) The SLC26 gene family of multifunctional anion exchangers. Pflugers Arch-Eur J Physiol 447: 710
20.
Hodgkinson A, Wilkinson R (1974) Plasma oxalate concentration and renal excretion of oxalate in man. Clin Sci Mol Med 46: 61PubMed
21.
Prenen JAC, Boer P, Mees EJD, Endeman HJ, Spoor SM, Oei HY (1982) Renal clearance of [14C]oxalate:comparison of constant-infusion with single-injection techniques. Clin Sci 63: 47PubMed
22.
Greger R, Lang F, Oberleithner H, Deetjen P (1978) Handling of oxalate by the rat kidney. Pflugers Arch 374: 243PubMed
23.
Schwille PO, Manoharan M, Rumenapf G, Wolfel G, Berens H (1989) Oxalate measurement in the picomol range by ion chromatography: values in fasting plasma and urine of controls and patients with idiopathic calcium urolithiasis. J Clin Chem Clin Biochem 27: 87PubMed
24.
Cattell WR, Spencer AG, Taylor GW, Watts RWE (1962) The mechanism of the renal excretion of oxalate in the dog. Clin Sci 22: 43PubMed
25.
Williams HE, Johnson GA, Smith LH (1971) The renal clearance of oxalate in normal subjects and patients with primary hyperoxaluria. Clin Sci 41: 213PubMed
26.
Weinman EJ, Frankfurt SJ, Ince A, Sansom S (1978) Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat. J Clin Invest 61: 801PubMed
27.
Tremaine LM, Bird JE, Quebbemann AJ (1985) Renal tubular excretory transport of oxalate. J Pharmacol Exp Therap 233: 7
28.
Knight TF, Sansom SC, Senekjian HO, Weinman EJ (1981) Oxalate secretion in the rat proximal tubule. AmeJ Physiol 240: F295
29.
Markovich D, Bissig M, Sorribas V, Hagenbuch B, Meier PJ, Murer H (1994) Expression of rat renal sulfate transport systems in Xenopus laevis oocytes. J Biol Chem 269: 3022PubMed
30.
Karniski LP, Lotscher M, Fucentese M, Hilfiker H, Biber J, Murer H (1998) Immunolocalization of sat-1 sulfate/oxalate/bicarbonate anion exchanger in the rat kidney. Am J Physiol 275: F79
31.
Jiang Z, Grichtchenko II, Boron WF, Aronson PS (2002) Specificity of anion exchange mediated by mouse slc26a6. J Biol Chem 277: 33963CrossRefPubMed
32.
Xie Q, Welch R, Mercado A, Romero MF, Mount DM (2002) Molecular characterization of the murine Slc26a6 anion exchanger: functional comparison with Slc26a1. Am J Physiol 283: F826
33.
Lohi H, Kujala M, Makela S, Lehtonen E, Kestila M, Saarialho-Kere U, Markovich D, Kere J (2002) Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. J Biol Chem 277: 14246CrossRefPubMed
34.
Knauf F, Yang C-L, Thomson RB, Mentone AA, Giebisch G, Aronson PS (2001) Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells. Proc Natl Acad Sci U S A 98: 9425CrossRefPubMed
35.
Lohi H, Lamprecht G, Markovich D, Heil A, Kujala M, Seidler U, Kere J (2003) Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains. Am J Physiol 284: C769
36.
Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30: 35PubMed
37.
Jonassen JA, Cao LC, Honeyman T, Scheid CR (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13: 55PubMed
38.
Fan J, Chandhkoe PS (1999) Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique. J Urol 161: 1685PubMed
39.
Koul S, Chaturvedi LS, Sekhon A, Bhandari A, Menon M, Koul HK (2002) Effects of oxalate on the re-initiation of DNA synthesis in LLC-PK1 cells do not involve p42/44 MAP kinase activation. Kidney Int 61: 525CrossRefPubMed
40.
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77
41.
Albihn PBE, Savage GP (2001) The bioavailability of oxalate from oca (Oxalis tuberosa). J Urol 166: 420CrossRefPubMed
42.
Massey LK, Grentz LM, Horner HT, Palmer RG (2002) Soybean and soyfood consumption increase oxalate excretion. Top Clin Nutr 17: 49
43.
Brinkley L, McGuire J, Gregory J, Pak CY (1981) Bioavailability of oxalate in foods. Urology 17: 534PubMed
44.
Brogren M, Savage GP (2003) Bioavailability of soluble oxalate from spinach eaten with and without milk products. Asia Pacific J Clin Nutr 12: 219
45.
Savage GP, Charrier MJS, Vanhanen L (2003) Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr 57: 415CrossRefPubMed
46.
Barilla DE, Notz C, Kennedy D, Pak CYC (1978) Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium. Am J Med 64: 579CrossRefPubMed
Metadata
Title
The impact of dietary oxalate on kidney stone formation
Authors
Ross P. Holmes
Dean G. Assimos
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 5/2004
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-004-0437-3

Other articles of this Issue 5/2004

Urolithiasis 5/2004 Go to the issue

Original Paper

Expression of transforming growth factor β in renal cell carcinoma and matched non-involved renal tissue

Original Paper

The effect of sustained and local administration of epidermal growth factor on improving bilateral testicular tissue after torsion

Original Paper

Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients

Original Paper

Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers

Original Paper

Comparative analysis of different apoptosis detection methods in human testicular cancer

Original Paper

Raxofelast, a hydrophilic vitamin e-like antioxidant, reduces testicular ischemia-reperfusion injury